(Q24198148)

2

0 references

Juliet Hockenhull

3

0 references

Mary Gemma Cherry

4

0 references

Max K Bulsara

5

0 references

Michael Daniels

6

0 references

J.N.G. Oude Elberink

Cochrane Database of Systematic Reviews

7

0 references

publication date

17 October 2012

0 references

published in

0 references

cites work

Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Venom immunotherapy reduces large local reactions to insect stings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

A controlled trial of immunotherapy in insect hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

The value of immunotherapy with venom in children with allergy to insect stings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Combination of passive and active immunization in honeybee venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Clustered immunotherapy with Yellow Jacket venom. Evaluation of the influence of time interval on in vivo and in vitro parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Venom immunotherapy in hymenoptera sting allergy. Comparison of rush and conventional hyposensitization and observations during long-term treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Premedication with montelukast reduces local reactions of allergen immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Epidemiology of Hymenoptera allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

The natural history and epidemiology of insect venom allergy: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Diagnosis of Hymenoptera venom allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Clinical features and severity grading of anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Immunotherapy: The meta-analyses. What have we Learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Hymenoptera venom allergy: characteristics, tolerance and efficacy of immunotherapy in the paediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

New insight into immunological mechanisms of venom immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Imported fire ant immunotherapy: effectiveness of whole body extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Insect sting allergy and venom immunotherapy: a model and a mystery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Stinging insect hypersensitivity: a practice parameter update 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

A simple 3-day "rush" venom immunotherapy protocol: documentation of safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Anaphylaxis fatalities and admissions in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Stinging insect hypersensitivity: a practice parameter update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Diagnosis and treatment of insect sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Bee venom allergy in beekeepers and their family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Quality of life in insect venom allergic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Lessons for management of anaphylaxis from a study of fatal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Systematic reviews of sublingual immunotherapy (SLIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensiti

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Specific ultrarush desensitization in Hymenoptera venom-allergic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

Specific immunotherapy using Hymenoptera venom: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

A comparative study of IgG subclass antibodies in patients allergic to wasp or bee venom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

A double-blind study comparing monomethoxy polyethylene glycol-modified honeybee venom and unmodified honeybee venom for immunotherapy. I. Clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

7 January 2021

Epidemiology of anaphylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

7 January 2021

Mechanisms of allergen-specific immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

7 January 2021

Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

7 January 2021

Epidemiologic study of insect allergy in children. II. Effect of accidental stings in allergic children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

7 January 2021

Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

7 January 2021

Outcomes of allergy to insect stings in children, with and without venom immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

7 January 2021

A preliminary study of immunotherapy with a monomethoxy polyethylene glycol modified honey bee venom preparation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

7 January 2021

Immunotherapy with yellow jacket venom. A comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

7 January 2021

A cutaneous allergen neutralisation test that correlates with the duration of venom immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008838.PUB2

7 January 2021

10.1002/14651858.CD008838.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2827575

OpenCitations bibliographic resource ID

2827575

1 reference